Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland.

Chappuy H, Keitel K, Gehri M, Tabin R, Robitaille L, Raymond F, Corbeil J, Maspoli V, Bouazza N, Alcoba G, Lacroix L, Manzano S, Galetto-Lacour A, Gervaix A.

BMC Infect Dis. 2013 Jul 31;13:357. doi: 10.1186/1471-2334-13-357.

2.

Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.

Zuccotti G, Mameli C, Daprai L, Garlaschi ML, Dilillo D, Bedogni G, Faccini M, Gramegna M, Torresani E; PneuMi Study Group (PMSG)., Ballerini E, Benincaso A, Bonvissuto M, Bricalli D, Brioschi M, Calloni CS, Camiletti MI, Colella G, De Angelis L, Decarlis S, Di Nello F, Dozzi M, Galli E, Gandini V, Giuliani MG, Laviola F, Loda B, Macedoni M, Mazzucchi E, Metta MG, Moscatiello A, Nannini P, Petruzzi M, Picicco D, Picciotti M, Pisanelli S, Porta N, Ramponi G, Redaelli F, Rubini R, Sala N, Saitta V, Scelza G, Tiso RM, Tomasetto M, Torcoletti M, Travaini M, Valentini M, Vessia C.

Vaccine. 2014 Jan 23;32(5):527-34. doi: 10.1016/j.vaccine.2013.12.003. Epub 2013 Dec 14.

PMID:
24342249
3.

Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.

Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, Beall B, Satola S, Jerris R, Jain S, Farley MM, Nuorti JP.

Pediatr Infect Dis J. 2013 Feb;32(2):e45-53. doi: 10.1097/INF.0b013e3182788fdd.

PMID:
23080290
4.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

5.

Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR.

Pasinato A, Indolfi G, Marchisio P, Valleriani C, Cortimiglia M, Spanevello V, Chiamenti G, Buzzetti R, Resti M, Azzari C; Italian Group for the Study of Bacterial Nasopharyngeal Carriage in Children..

Vaccine. 2014 Mar 10;32(12):1375-81. doi: 10.1016/j.vaccine.2014.01.023. Epub 2014 Jan 28.

PMID:
24486364
6.

Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.

Dagan R, Patterson S, Juergens C, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA.

Clin Infect Dis. 2013 Oct;57(7):952-62. doi: 10.1093/cid/cit428. Epub 2013 Jun 26.

PMID:
23804191
7.

Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.

Parra EL, De La Hoz F, Díaz PL, Sanabria O, Realpe ME, Moreno J.

Vaccine. 2013 Aug 20;31(37):4033-8. doi: 10.1016/j.vaccine.2013.04.074. Epub 2013 May 14.

PMID:
23680440
8.

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.

van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E.

Vaccine. 2014 Jul 23;32(34):4349-55. doi: 10.1016/j.vaccine.2014.03.017. Epub 2014 Mar 21.

PMID:
24657717
9.

Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?

Azzari C, Cortimiglia M, Nieddu F, Moriondo M, Indolfi G, Mattei R, Zuliani M, Adriani B, Degl'Innocenti R, Consales G, Aquilini D, Bini G, Di Natale ME, Canessa C, Ricci S, de Vitis E, Mangone G, Bechini A, Bonanni P, Pasinato A, Resti M.

Hum Vaccin Immunother. 2016;12(2):344-50. doi: 10.1080/21645515.2015.1102811.

10.

Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.

Wroe PC, Lee GM, Finkelstein JA, Pelton SI, Hanage WP, Lipsitch M, Stevenson AE, Rifas-Shiman SL, Kleinman K, Dutta-Linn MM, Hinrichsen VL, Lakoma M, Huang SS.

Pediatr Infect Dis J. 2012 Mar;31(3):249-54. doi: 10.1097/INF.0b013e31824214ac.

11.

The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: Comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduction.

Nunes S, Félix S, Valente C, Simões AS, Tavares DA, Almeida ST, Paulo AC, Brito-Avô A, de Lencastre H, Sá-Leão R.

Vaccine. 2016 Mar 29;34(14):1648-56. doi: 10.1016/j.vaccine.2016.02.045. Epub 2016 Feb 23.

PMID:
26920470
12.

Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.

Ben-Shimol S, Givon-Lavi N, Greenberg D, Dagan R.

Hum Vaccin Immunother. 2016;12(2):268-76. doi: 10.1080/21645515.2015.1095414.

13.

Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.

Desai AP, Sharma D, Crispell EK, Baughman W, Thomas S, Tunali A, Sherwood L, Zmitrovich A, Jerris R, Satola SW, Beall B, Moore MR, Jain S, Farley MM.

Pediatr Infect Dis J. 2015 Nov;34(11):1168-74. doi: 10.1097/INF.0000000000000849.

PMID:
26226445
14.

Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.

Esposito S, Principi N; ESCMID Vaccine Study Group..

Future Microbiol. 2015;10(10):1599-607. doi: 10.2217/fmb.15.81. Epub 2015 Oct 6.

PMID:
26439470
15.

Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.

Nunes MC, Jones SA, Groome MJ, Kuwanda L, Van Niekerk N, von Gottberg A, de Gouveia L, Adrian PV, Madhi SA.

Vaccine. 2015 Jan 29;33(5):628-34. doi: 10.1016/j.vaccine.2014.12.023. Epub 2014 Dec 23.

PMID:
25541213
16.

Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.

Cohen R, Levy C, Bingen E, Koskas M, Nave I, Varon E.

Pediatr Infect Dis J. 2012 Mar;31(3):297-301. doi: 10.1097/INF.0b013e318247ef84.

PMID:
22330166
17.

Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.

Grivea IN, Priftis KN, Giotas A, Kotzia D, Tsantouli AG, Douros K, Michoula AN, Syrogiannopoulos GA.

Vaccine. 2014 Nov 12;32(48):6513-20. doi: 10.1016/j.vaccine.2014.09.016. Epub 2014 Sep 22.

PMID:
25252194
18.

Carriage of Haemophilus influenzae is associated with pneumococcal vaccination in Italian children.

Camilli R, Vescio MF, Giufrè M, Daprai L, Garlaschi ML, Cerquetti M, Pantosti A.

Vaccine. 2015 Aug 26;33(36):4559-64. doi: 10.1016/j.vaccine.2015.07.009. Epub 2015 Jul 16.

PMID:
26190092
19.

Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay.

Pletz MW, Ewig S, Rohde G, Schuette H, Rupp J, Welte T, Suttorp N, Forstner C; CAPNETZ Study Group..

Vaccine. 2016 Apr 29;34(20):2342-8. doi: 10.1016/j.vaccine.2016.03.052. Epub 2016 Mar 24.

PMID:
27016653
20.

A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.

Cohen R, Varon E, Doit C, Schlemmer C, Romain O, Thollot F, Béchet S, Bonacorsi S, Levy C.

Vaccine. 2015 Sep 22;33(39):5118-26. doi: 10.1016/j.vaccine.2015.08.010. Epub 2015 Aug 11.

PMID:
26271823

Supplemental Content

Support Center